期刊文献+

系统性红斑狼疮患者外周血淋巴细胞亚群分析 被引量:3

Analysis of the lymphocyte cell subsets in peripheral blood of patients with systemic lupus erythematosus
下载PDF
导出
摘要 目的探讨T淋巴细胞亚群、B淋巴细胞和NK细胞在系统性红斑狼疮(SLE)中的作用。方法利用流式细胞仪对29例活动期、24例非活动期SLE患者及50例健康对照者的外周血中的CD3+、CD4+、CD8+、CD3-CD16+CD56+(NK)及CD19+(B)淋巴细胞进行检测。结果活动期组与非活动期组及健康对照组比较:CD4+T淋巴细胞、CD4+/CD8+比值及NK细胞明显降低(P<0.05),B淋巴细胞明显增高(P<0.05),CD3+T和CD8+T淋巴细胞无统计学意义(P>0.05)。非活动期组与健康对照组比较,T淋巴细胞各亚群、NK细胞及B淋巴细胞均无统计学意义(P>0.05)。结论检测外周血淋巴细胞亚群,对判断病情及指导临床治疗具有重要意义。 Objective To investigate the role of T lymphocyte cell subsets, B cells and NK cells in systemic lupus erythe- matosus (SLE). Methods A total of 29 SLE patients in active phase, 24 SLE patients in quiescent phase and 50 healthy controls were enrolled. The CD3+, CD4+, CD8+, CD3-CD16+CD56+ (NK) and CD19+(B) cells in peripheral blood of SLE patients and healthy controls were detected by flow cytometry. Results Compared with the SLE patients in quiescent phase and healthy controls, there was significant difference in CD4+, CD4+/CD8+, B and NK cells in active phase SLE patients(P〈0.05), and no significant difference in CD8+ cells in active phase SLE patients (P〉0.05).There was no significant difference in CD3+,CD4+,CD8+, CD3-CD16+CD56+(NK) and CD19+(B) cells between quiescent phase SLE patients and healthy controls. Conclusion Lymphocyte cell subsets may play an important role in the pathogenesis, progression and therapy of SLE.
出处 《实验与检验医学》 CAS 2014年第2期142-143,152,共3页 Experimental and Laboratory Medicine
关键词 系统性红斑狼疮 T细胞亚群 B淋巴细胞 NK细胞 流式细胞术 Systemic lupus erythematosus T lymphocyte cell subsets B cells NK cells Flow cytometry
  • 相关文献

参考文献13

  • 1叶任高.内科学[m]第5版[M].北京:人民卫生出版社,2001.306.
  • 2叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2007:466-472.
  • 3Hochberg MC. Updating the american college of rheumatolo gy re- vised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum,1997,40(9):lT- 25.
  • 4Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI. A dise aseactivity index for lupus patients.The Committee on Prognosis. Studies in SLE[J]. Arthritis Rheum,1992,35(6):630- 640.
  • 5Raziuddin S,Nur MA,Alwabel AA.Increased circulating HLA-DR CD4+ T cells in systemic lupus erythematosus:olterations associated with prednisolone therapy [J].Scand J Immunol,1990,1 (2):139- 145.
  • 6Bacchetra R,Passerini L,Gambineri E.Defective regulatory and ef- fector T cell functions in patients with FOXP3 mutations [J].J Clin Invest,2006,16(6) : 1713-1722,.
  • 7Meada N,Sekigawa I,Iida N,et al. Relationship between CD4+/ CD8 T cell ratio and T cell activation in systemic Lupus erythe- matousus[J].Scand Rheumatd,1999,28(3):166-170.
  • 8Hasegaw AK,Hayashi T,Maeda K.Promotion of lupus in NZB x NZWF1 mice by plasmids encoding interferon (ifn)-, but not by those encoding interleukin (IL)-4[J].J Comp Pathol,2002,127(1):l- 6.
  • 9Amel-Kashipaz MR, Huggins ML, Lanyon P,et al. Quantitative and qualitative analysis of the balance between type 1 and type 2 cy- tokine-producing CD8 (-) and CD8 (+) T cells in systemic lupus erythematosus[J].J Autoimmun,2001,17(2):155-163.
  • 10Solomou EE,Yuang TJ,Gourley MF,et al. Molecular basis of defi- cient IL-2 production in T Ceils from patients with systemic lupus erythematosus[J].J Immun,200 l, 166(6):4216-4222.

二级参考文献6

共引文献383

同被引文献43

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部